This is my assignment done during my master's degree in Management of Bioeconomy Innovation and Governance to produce a poster on recent debates and issues in Bioeconomy sector.

1. Innogen Institute
The University of Edinburgh
Edinburgh, EH1 1LZ
www.innogen.ac.uk
1) Background
 Since its commercialization (1996), GM
crops :controversial issue that has
impact the world.
 World progression- astounding
 Europe ambition of Horizon 2020- to
ensure Europe produce world class
science, remove innovation barriers, and
make it easy for public and private to
deliver innovation.
 Recent news: EU member states to
restrict/ban GMO
4) A halt in GM crops - Similar to the
pharmaceutical industry dilemma?
3)Pros and Cons to new legislation2) EU progression with GM Crops
SCIENCE
-food safety research
(£260 million)
-lack funding for
applied plant
research
SOCIETY
-Public opinion (hard
to measure)
-Activist (Vocal)
AVAILABILITY
- GM crops cultivated
MON 810
-Imported products
Major importer for
agriculture goods.
Assessments: EFSA
POLICY MAKERS
- Placed moratorium on
approvals of GMO in
2001
-2001-Allows for GM
cultivation under tight
regulations
- June 2014- allowing
EU member states to
restrict/ban GMO
5) Suggestions
Rebranding
Knowledge transfer
(academia- producers
and consumers)
Allowing
transparency
Observe GM Crop
individually instead as
a whole
Realize the potential
References
1. Rt Hon Owen Paterson MP speech to Rothamsted Research 20 June
2012
2. MEPs vote to allow countries to ban GM crop cultivation-retrieved
11/11/2014.
3. Nightingale, P and Martin P. (2004) The myth of the biotech
revolution
4. Munos, B. (2009) Lessons from 60 years of pharmaceutical innovation
DON’T KNOCK GM CROPS JUST YET EU
 Not a matter of being left behind in economics,
but more on the science potential.
Unrealistic ideas
could kill- over
estimating the
potential or
under estimating
a certain
technology will
not end well.
A constant
graph for
output is
not
satisfactory
.
High
failure
rates
Pros Cons
The best in both
worlds
Further ruin GMOs
image
Addressing fear in
certain groups
Eliminating any chance
for funded applied
plant research